Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care

this study is aiming at learning more about primary ciliary dyskinesia (PCD) and tests that are used to diagnose this condition. One purpose of this study is to measure the level of nitric oxide in the nasal passages and examine how often the results correlate with other tests currently done to make the diagnosis.

NCT Number	NCT05287022
Lead Sponsor	Arkansas Children's Hospital Research Institute
Conditions	Primary Ciliary Dyskinesia
Enrollment	150 participants
Start Date	2021-06-14
Primary Completion	2030-06 (estimated)
Study Completion	2030-06 (estimated)
Updated on ClinicalTrials.gov	2025-01-30